In addition, Nf1 loss or HRAS-G12V RASopathy mutations have also been shown to impact mature and myelinating oligodendrocytes (Mayes et al., 2013; Lopez-Juarez et al., 2017; Titus et al., 2017). This evidence concerns the gene NF1 and RASopathy.